Will 2024 be the Year We Address the Real Roots of the Opioid Crisis?
Will 2024 bring any change, or will we witness yet another record- and heart-breaking year of preventable deaths?
Why Federally Mandated Electronic Prescribing for Controlled Substances will Benefit Public Health
Today, 35 states have passed mandates for electronic prescriptions for controlled substances with the aim being to reduce the risk of stolen or forged prescriptions and to prevent patients from ‘doctor shopping’ between states.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
ISO: What You Need To Know About The Deadly New Drug
It’s called ISO, short for isotonitazine, a deadly synthetic opioid that is 100X to 1000X stronger than morphine and 20X more potent than fentanyl.
New National Tracker for Non-fatal Overdoses Is ‘a Step in the Right Direction’ to End the Opioid Crisis
The White House launched a new initiative to address the country’s opioid crisis — a dashboard tracking non-fatal opioid overdoses. The new tool is meant to track overdose clusters to inform better medical responses and preparedness.
Pennsylvania pharmacy owner must pay $4M for “no questions asked” oxycodone sales
A neighborhood pharmacy owner was the largest purchaser of oxycodone among retail pharmacies in the entire state of Pennsylvania by 2016 and pled guilty to charges of conspiracy and fraud.
A needle exchange project modeled on urban efforts aims to save lives in rural Nevada
Richard Cusolito believes he’s saving lives by distributing clean syringes and needles to people who use drugs in Elko, a rural area of northeastern Nevada — but he knows some residents disagree. “I’m hated in this town because of it,” said Cusolito, 60. “I’m accused of ‘enabling the junkies,’ pretty much is the standard term. […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Ohio’s $650 million opioid ruling against major pharmacies may spook pharmacists
"This decision sends pharmacists a dangerous message: you're expected to overrule doctors - and not doing so can be costly."
New York AG: Teva USA’s parent company shouldn’t be allowed to escape opioid liability
Without the parent company, there's concern Teva won't be able to pay billions in reward to NY state.
Why stigma continues to exacerbate the United States’ drug epidemic
Since we know the fundamental causes of the opioid epidemic, why are we still here? It all centers around stigma.
Jury rules pharmacy chains liable in landmark opioid trial
A federal jury found pharmacy chains CVS, Walgreens and Walmart helped fuel the opioid epidemic in two Ohio counties. It’s the first trial pharmacy chains have faced related to the opioid crisis, though several other lawsuits have been filed.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Let’s address the opioid crisis with the same resolve as Covid-19
We urge Congress to quickly pass the NOPAIN Act and help fight the opioid epidemic with the same fervor we’ve battled Covid-19.
Addressing the Covid-19 and Opioid “Twindemic”
The past year has taught everyone the value of a more compassionate and non-punitive approach toward just about everything. Now, it’s time for leaders to take that approach and apply it, with supportive data and knowledge, to mitigating opioid addiction in their communities.
Opioid overdoses are spiking amid the pandemic – PBMs can help combat opioid abuse and misuse
Opioid overutilization is a public health crisis, and PBMs with programs aimed at curbing abuse and educating providers can have a positive and substantial impact on clients and their members.
Purdue Pharma accused of causing $2.2T in damages amid opioid epidemic
Nearly all of the states, plus five territories and the District of Columbia, are seeking an aggregate of $2.156 trillion from the maker of the opioid painkiller OxyContin, according to documents filed in the U.S. Bankruptcy Court Monday.
Physical therapy can create a path for reduced opioid use
Opioid abuse is a widely recognized public health crisis in the United States and the detrimental effects are wide-ranging and severe. Individuals in pain, especially chronic pain, are more likely to use opioids. The coronavirus pandemic (Covid-19) has the potential to exacerbate opioid and other drug use. Research suggests that opioid use can worsen pain […]